aluates Reports

$ 0.0

Automative

Global Respiratory Syncytial Virus Vaccines Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-23K10379

Global Respiratory Syncytial Virus Vaccines Market Research Report 2022

BUY CHAPTERS

Global Respiratory Syncytial Virus Vaccines Market Research Report 2025

Code: QYRE-Auto-23K10379

Report

March 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Merck Sharp & Dohme

GlaxoSmithKline PLC

SOBI

Johnson & Johnson

Bavarian Nordic

Novavax Inc

Astrazeneca plc

Moderna, Inc

Codagenix

Intravacc

AlphaVax

Pfizer Inc.Pfizer Inc.

Respiratory Syncytial Virus Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Respiratory Syncytial Virus Vaccines Market

The global market for Respiratory Syncytial Virus Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Vaccines.

The Respiratory Syncytial Virus Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Syncytial Virus Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Respiratory Syncytial Virus Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Respiratory Syncytial Virus Vaccines Market Report

Report Metric	Details
Report Name	Respiratory Syncytial Virus Vaccines Market
CAGR	5%
Segment by Type	Palivizumab RSVpreF PF06928316 RSVPreF3 OA (GSK3844766A) mRNA-1345 Janssen RSV Vaccine ResVax Nirsevimab (MEDI8897) MVA-BN RSV
Segment by Application	Hospital Clinic Research Institute
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc.Pfizer Inc., Sanofi, Merck Sharp & Dohme, GlaxoSmithKline, SOBI, Johnson & Johnson, Bavarian Nordic, Novavax, AstraZeneca, Moderna, Codagenix, Intravacc, Alphavax
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Syncytial Virus Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Respiratory Syncytial Virus Vaccines Market report?

Ans: The main players in the Respiratory Syncytial Virus Vaccines Market are Pfizer Inc.Pfizer Inc., Sanofi, Merck Sharp & Dohme, GlaxoSmithKline, SOBI, Johnson & Johnson, Bavarian Nordic, Novavax, AstraZeneca, Moderna, Codagenix, Intravacc, Alphavax

What are the Application segmentation covered in the Respiratory Syncytial Virus Vaccines Market report?

Ans: The Applications covered in the Respiratory Syncytial Virus Vaccines Market report are Hospital, Clinic, Research Institute

What are the Type segmentation covered in the Respiratory Syncytial Virus Vaccines Market report?

Ans: The Types covered in the Respiratory Syncytial Virus Vaccines Market report are Palivizumab, RSVpreF PF06928316, RSVPreF3 OA (GSK3844766A), mRNA-1345, Janssen RSV Vaccine, ResVax, Nirsevimab (MEDI8897), MVA-BN RSV

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Palivizumab

1.2.3 RSVpreF PF06928316

1.2.4 RSVPreF3 OA (GSK3844766A)

1.2.5 mRNA-1345

1.2.6 Janssen RSV Vaccine

1.2.7 ResVax

1.2.8 Nirsevimab (MEDI8897)

1.2.9 MVA-BN RSV

1.3 Market by Application

1.3.1 Global Respiratory Syncytial Virus Vaccines Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Research Institute

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Respiratory Syncytial Virus Vaccines Market Perspective (2020-2031)

2.2 Global Respiratory Syncytial Virus Vaccines Growth Trends by Region

2.2.1 Global Respiratory Syncytial Virus Vaccines Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Respiratory Syncytial Virus Vaccines Historic Market Size by Region (2020-2025)

2.2.3 Respiratory Syncytial Virus Vaccines Forecasted Market Size by Region (2026-2031)

2.3 Respiratory Syncytial Virus Vaccines Market Dynamics

2.3.1 Respiratory Syncytial Virus Vaccines Industry Trends

2.3.2 Respiratory Syncytial Virus Vaccines Market Drivers

2.3.3 Respiratory Syncytial Virus Vaccines Market Challenges

2.3.4 Respiratory Syncytial Virus Vaccines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Respiratory Syncytial Virus Vaccines Players by Revenue

3.1.1 Global Top Respiratory Syncytial Virus Vaccines Players by Revenue (2020-2025)

3.1.2 Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Players (2020-2025)

3.2 Global Respiratory Syncytial Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Respiratory Syncytial Virus Vaccines Revenue

3.4 Global Respiratory Syncytial Virus Vaccines Market Concentration Ratio

3.4.1 Global Respiratory Syncytial Virus Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Vaccines Revenue in 2024

3.5 Global Key Players of Respiratory Syncytial Virus Vaccines Head office and Area Served

3.6 Global Key Players of Respiratory Syncytial Virus Vaccines, Product and Application

3.7 Global Key Players of Respiratory Syncytial Virus Vaccines, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Syncytial Virus Vaccines Breakdown Data by Type

4.1 Global Respiratory Syncytial Virus Vaccines Historic Market Size by Type (2020-2025)

4.2 Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Type (2026-2031)

5 Respiratory Syncytial Virus Vaccines Breakdown Data by Application

5.1 Global Respiratory Syncytial Virus Vaccines Historic Market Size by Application (2020-2025)

5.2 Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Respiratory Syncytial Virus Vaccines Market Size (2020-2031)

6.2 North America Respiratory Syncytial Virus Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Respiratory Syncytial Virus Vaccines Market Size by Country (2020-2025)

6.4 North America Respiratory Syncytial Virus Vaccines Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Respiratory Syncytial Virus Vaccines Market Size (2020-2031)

7.2 Europe Respiratory Syncytial Virus Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2020-2025)

7.4 Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size (2020-2031)

8.2 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Region (2020-2025)

8.4 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Respiratory Syncytial Virus Vaccines Market Size (2020-2031)

9.2 Latin America Respiratory Syncytial Virus Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2020-2025)

9.4 Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size (2020-2031)

10.2 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2020-2025)

10.4 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer Inc.Pfizer Inc.

11.1.1 Pfizer Inc.Pfizer Inc. Company Details

11.1.2 Pfizer Inc.Pfizer Inc. Business Overview

11.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Introduction

11.1.4 Pfizer Inc.Pfizer Inc. Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.1.5 Pfizer Inc.Pfizer Inc. Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Respiratory Syncytial Virus Vaccines Introduction

11.2.4 Sanofi Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 Merck Sharp & Dohme

11.3.1 Merck Sharp & Dohme Company Details

11.3.2 Merck Sharp & Dohme Business Overview

11.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Introduction

11.3.4 Merck Sharp & Dohme Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.3.5 Merck Sharp & Dohme Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Introduction

11.4.4 GlaxoSmithKline Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.4.5 GlaxoSmithKline Recent Development

11.5 SOBI

11.5.1 SOBI Company Details

11.5.2 SOBI Business Overview

11.5.3 SOBI Respiratory Syncytial Virus Vaccines Introduction

11.5.4 SOBI Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.5.5 SOBI Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Introduction

11.6.4 Johnson & Johnson Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.6.5 Johnson & Johnson Recent Development

11.7 Bavarian Nordic

11.7.1 Bavarian Nordic Company Details

11.7.2 Bavarian Nordic Business Overview

11.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Introduction

11.7.4 Bavarian Nordic Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.7.5 Bavarian Nordic Recent Development

11.8 Novavax

11.8.1 Novavax Company Details

11.8.2 Novavax Business Overview

11.8.3 Novavax Respiratory Syncytial Virus Vaccines Introduction

11.8.4 Novavax Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.8.5 Novavax Recent Development

11.9 AstraZeneca

11.9.1 AstraZeneca Company Details

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Introduction

11.9.4 AstraZeneca Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.9.5 AstraZeneca Recent Development

11.10 Moderna

11.10.1 Moderna Company Details

11.10.2 Moderna Business Overview

11.10.3 Moderna Respiratory Syncytial Virus Vaccines Introduction

11.10.4 Moderna Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.10.5 Moderna Recent Development

11.11 Codagenix

11.11.1 Codagenix Company Details

11.11.2 Codagenix Business Overview

11.11.3 Codagenix Respiratory Syncytial Virus Vaccines Introduction

11.11.4 Codagenix Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.11.5 Codagenix Recent Development

11.12 Intravacc

11.12.1 Intravacc Company Details

11.12.2 Intravacc Business Overview

11.12.3 Intravacc Respiratory Syncytial Virus Vaccines Introduction

11.12.4 Intravacc Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.12.5 Intravacc Recent Development

11.13 Alphavax

11.13.1 Alphavax Company Details

11.13.2 Alphavax Business Overview

11.13.3 Alphavax Respiratory Syncytial Virus Vaccines Introduction

11.13.4 Alphavax Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025)

11.13.5 Alphavax Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Merck Sharp & Dohme

GlaxoSmithKline PLC

SOBI

Johnson & Johnson

Bavarian Nordic

Novavax Inc

Astrazeneca plc

Moderna, Inc

Codagenix

Intravacc

AlphaVax

Pfizer Inc.Pfizer Inc.

List of Tables

Table 1. Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Palivizumab

Table 3. Key Players of RSVpreF PF06928316

Table 4. Key Players of RSVPreF3 OA (GSK3844766A)

Table 5. Key Players of mRNA-1345

Table 6. Key Players of Janssen RSV Vaccine

Table 7. Key Players of ResVax

Table 8. Key Players of Nirsevimab (MEDI8897)

Table 9. Global Respiratory Syncytial Virus Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Respiratory Syncytial Virus Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Respiratory Syncytial Virus Vaccines Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Respiratory Syncytial Virus Vaccines Market Share by Region (2020-2025)

Table 13. Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Respiratory Syncytial Virus Vaccines Market Share by Region (2026-2031)

Table 15. Respiratory Syncytial Virus Vaccines Market Trends

Table 16. Respiratory Syncytial Virus Vaccines Market Drivers

Table 17. Respiratory Syncytial Virus Vaccines Market Challenges

Table 18. Respiratory Syncytial Virus Vaccines Market Restraints

Table 19. Global Respiratory Syncytial Virus Vaccines Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Respiratory Syncytial Virus Vaccines Market Share by Players (2020-2025)

Table 21. Global Top Respiratory Syncytial Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Vaccines as of 2024)

Table 22. Ranking of Global Top Respiratory Syncytial Virus Vaccines Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Respiratory Syncytial Virus Vaccines Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Respiratory Syncytial Virus Vaccines, Headquarters and Area Served

Table 25. Global Key Players of Respiratory Syncytial Virus Vaccines, Product and Application

Table 26. Global Key Players of Respiratory Syncytial Virus Vaccines, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Respiratory Syncytial Virus Vaccines Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Type (2020-2025)

Table 30. Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Type (2026-2031)

Table 32. Global Respiratory Syncytial Virus Vaccines Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Application (2020-2025)

Table 34. Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Application (2026-2031)

Table 36. North America Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Respiratory Syncytial Virus Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Respiratory Syncytial Virus Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 51. Pfizer Inc.Pfizer Inc. Company Details

Table 52. Pfizer Inc.Pfizer Inc. Business Overview

Table 53. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product

Table 54. Pfizer Inc.Pfizer Inc. Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 55. Pfizer Inc.Pfizer Inc. Recent Development

Table 56. Sanofi Company Details

Table 57. Sanofi Business Overview

Table 58. Sanofi Respiratory Syncytial Virus Vaccines Product

Table 59. Sanofi Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 60. Sanofi Recent Development

Table 61. Merck Sharp & Dohme Company Details

Table 62. Merck Sharp & Dohme Business Overview

Table 63. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product

Table 64. Merck Sharp & Dohme Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 65. Merck Sharp & Dohme Recent Development

Table 66. GlaxoSmithKline Company Details

Table 67. GlaxoSmithKline Business Overview

Table 68. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product

Table 69. GlaxoSmithKline Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 70. GlaxoSmithKline Recent Development

Table 71. SOBI Company Details

Table 72. SOBI Business Overview

Table 73. SOBI Respiratory Syncytial Virus Vaccines Product

Table 74. SOBI Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 75. SOBI Recent Development

Table 76. Johnson & Johnson Company Details

Table 77. Johnson & Johnson Business Overview

Table 78. Johnson & Johnson Respiratory Syncytial Virus Vaccines Product

Table 79. Johnson & Johnson Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 80. Johnson & Johnson Recent Development

Table 81. Bavarian Nordic Company Details

Table 82. Bavarian Nordic Business Overview

Table 83. Bavarian Nordic Respiratory Syncytial Virus Vaccines Product

Table 84. Bavarian Nordic Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 85. Bavarian Nordic Recent Development

Table 86. Novavax Company Details

Table 87. Novavax Business Overview

Table 88. Novavax Respiratory Syncytial Virus Vaccines Product

Table 89. Novavax Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 90. Novavax Recent Development

Table 91. AstraZeneca Company Details

Table 92. AstraZeneca Business Overview

Table 93. AstraZeneca Respiratory Syncytial Virus Vaccines Product

Table 94. AstraZeneca Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 95. AstraZeneca Recent Development

Table 96. Moderna Company Details

Table 97. Moderna Business Overview

Table 98. Moderna Respiratory Syncytial Virus Vaccines Product

Table 99. Moderna Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 100. Moderna Recent Development

Table 101. Codagenix Company Details

Table 102. Codagenix Business Overview

Table 103. Codagenix Respiratory Syncytial Virus Vaccines Product

Table 104. Codagenix Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 105. Codagenix Recent Development

Table 106. Intravacc Company Details

Table 107. Intravacc Business Overview

Table 108. Intravacc Respiratory Syncytial Virus Vaccines Product

Table 109. Intravacc Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 110. Intravacc Recent Development

Table 111. Alphavax Company Details

Table 112. Alphavax Business Overview

Table 113. Alphavax Respiratory Syncytial Virus Vaccines Product

Table 114. Alphavax Revenue in Respiratory Syncytial Virus Vaccines Business (2020-2025) & (US$ Million)

Table 115. Alphavax Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Respiratory Syncytial Virus Vaccines Picture

Figure 2. Global Respiratory Syncytial Virus Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Respiratory Syncytial Virus Vaccines Market Share by Type: 2024 VS 2031

Figure 4. Palivizumab Features

Figure 5. RSVpreF PF06928316 Features

Figure 6. RSVPreF3 OA (GSK3844766A) Features

Figure 7. mRNA-1345 Features

Figure 8. Janssen RSV Vaccine Features

Figure 9. ResVax Features

Figure 10. Nirsevimab (MEDI8897) Features

Figure 11. MVA-BN RSV Features

Figure 12. Global Respiratory Syncytial Virus Vaccines Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Respiratory Syncytial Virus Vaccines Market Share by Application: 2024 VS 2031

Figure 14. Hospital Case Studies

Figure 15. Clinic Case Studies

Figure 16. Research Institute Case Studies

Figure 17. Respiratory Syncytial Virus Vaccines Report Years Considered

Figure 18. Global Respiratory Syncytial Virus Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Respiratory Syncytial Virus Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Respiratory Syncytial Virus Vaccines Market Share by Region: 2024 VS 2031

Figure 21. Global Respiratory Syncytial Virus Vaccines Market Share by Players in 2024

Figure 22. Global Top Respiratory Syncytial Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Vaccines as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus Vaccines Revenue in 2024

Figure 24. North America Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Respiratory Syncytial Virus Vaccines Market Share by Country (2020-2031)

Figure 26. United States Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Respiratory Syncytial Virus Vaccines Market Share by Country (2020-2031)

Figure 30. Germany Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Share by Region (2020-2031)

Figure 38. China Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Respiratory Syncytial Virus Vaccines Market Share by Country (2020-2031)

Figure 46. Mexico Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Share by Country (2020-2031)

Figure 50. Turkey Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Pfizer Inc.Pfizer Inc. Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 54. Sanofi Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 55. Merck Sharp & Dohme Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 56. GlaxoSmithKline Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 57. SOBI Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 58. Johnson & Johnson Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 59. Bavarian Nordic Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 60. Novavax Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 61. AstraZeneca Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 62. Moderna Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 63. Codagenix Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 64. Intravacc Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 65. Alphavax Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Respiratory Syncytial Virus RSV Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Syncytial Virus Fusion Protein Drug Market Research Report 2024

Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vaccines Market Research Report 2025

23 valent Pneumococcal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Paediatric Vaccine Market

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Shingles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Ampoules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Quadrivalent Flu Vaccine Market Insights Forecast to 2030

Pneumococcal Conjugate Vaccine PCV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IPV Vaccine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions